Recent Advances in Understanding the Molecular Mechanisms of Tamoxifen Action (Q47785739)

5 February 2018

review article

1 reference

title

Recent advances in understanding the molecular mechanisms of tamoxifen action (English)

1 reference

5 February 2018

Recent Advances in Understanding the Molecular Mechanisms of Tamoxifen Action (English)

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

1 January 2025

1 reference

Z. Y. Friedman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9679530

1 January 2025

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9679530

1 January 2025

publication date

1 January 1998

1 reference

5 February 2018

1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9679530

full work available at URL

1 January 2025

http://www.tandfonline.com/doi/pdf/10.3109/07357909809115779

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

1 January 2025

1 reference

5 February 2018

volume

16

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

391-396

1 reference

5 February 2018

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

cites work

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Scientific basis for cancer prevention. Intermediate cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Alternative mechanisms of action of anti-oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Regulation and role of TGF beta production in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Inositol trisphosphate and diacylglycerol: two interacting second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Hormone and growth factor receptor-mediated regulation of phospholipase C activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheobronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Bradykinin induces phosphoinositide turnover, 1,2-diglyceride formation, and growth in cultured adult human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2( )-mobilizing H1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Direct stimulation by thyrotropin-releasing hormone (TRH) of polyphosphoinositide hydrolysis in GH3 cell membranes by a guanine nucleotide-modulated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Phosphatidylinositol cleavage catalysed by the soluble fraction from lymphocytes. Activity at pH5.5 and pH7.0

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

The properties and subcellular distribution of phosphatidylinositol kinase in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Bovine brain contains two types of phosphatidylinositol kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

The diphosphoinositide kinase of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Catalytic properties of a purified phosphatidylinositol-4-phosphate kinase from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Evidence for a cholera-toxin-sensitive G-protein involved in the regulation of phosphatidylinositol 4-phosphate kinase of rat liver membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Interleukin 1 stimulates phosphatidylinositol kinase activity in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Evidence from two transformed cell lines that the phosphorylations of peptide tyrosine and phosphatidylinositol are catalyzed by different proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Inhibition of phosphatidylinositol-4-phosphate kinase by its product phosphatidylinositol-4,5-bisphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Antiestrogens and steroid hormones: substrates of the human P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen's role in chemoprevention of breast cancer: an update.

21 January 2018

8

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol

1 January 2025

9

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 January 2025

17

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity

1 January 2025

20

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells

1 January 2025

22

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells

1 January 2025

25

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Protein kinase C controls Fcγ receptor-mediated endocytosis in human neutrophils

1 January 2025

31

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme

1 January 2025

33

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Journal of the National Cancer Institute

1 January 2025

34

76

1243

O'Brian C A

1986

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Biochimica et Biophysica Acta

1 January 2025

37

907

33

Berridge M J

1987

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?

1 January 2025

39

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

The antioxidant action of synthetic oestrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen?

1 January 2025

41

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 January 2025

42

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling

1 January 2025

46

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro

1 January 2025

47

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Bombesin stimulates inositol polyphosphate production in GH4C1 pituitary tumor cells: comparison with TRH

1 January 2025

59

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

Purification and partial characterization of the phosphatidylinositol 4-phosphate kinase from rat brain

1 January 2025

68

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

A small G-protein involved in phosphatidylinositol-4-phosphate kinase activation

1 January 2025

71

1 reference

https://api.crossref.org/works/10.3109/07357909809115779

1 January 2025

Identifiers

1 reference

5 February 2018

1 reference

5 February 2018